Ideanomics, Inc.
IDEXQ
$0.005
-$0.025-83.33%
| Weiss Ratings | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -3.62 | |||
| Price History | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -83.33% | |||
| 30-Day Total Return | -90.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -97.50% | |||
| Year to Date Total Return | -90.00% | |||
| 1-Year Total Return | -99.48% | |||
| 2-Year Total Return | -99.96% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.64% | |||
| 52-Week Low % Change | 499,900.00% | |||
| Price | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.38 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 23, 2024 | |||
| 52-Week High Price (Date) | May 14, 2024 | |||
| Valuation | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 100.34K | |||
| Enterprise Value | 43.24M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -23.65 | |||
| Earnings Per Share Growth | -61.27% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 2.80 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -0.51 | |||
| Enterprise Value/EBIT | -0.42 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 12.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (212) 206-1216 | |||
| Address | 1441 Broadway New York, NY 10018 | |||
| Website | www.ideanomics.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -658.10% | |||
| Profit Margin | -1,447.88% | |||
| Management Effectiveness | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -34.97% | |||
| Return on Equity | -- | |||
| Income Statement | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 14.70M | |||
| Total Revenue (TTM) | 15.46M | |||
| Revenue Per Share | $1.29 | |||
| Gross Profit (TTM) | -2.71M | |||
| EBITDA (TTM) | -83.99M | |||
| EBIT (TTM) | -101.74M | |||
| Net Income (TTM) | -223.83M | |||
| Net Income Avl. to Common (TTM) | -223.83M | |||
| Total Revenue Growth (Q YOY) | 5,200.00% | |||
| Earnings Growth (Q YOY) | 67.25% | |||
| EPS Diluted (TTM) | -23.65 | |||
| EPS Diluted Growth (Q YOY) | 90.11% | |||
| Balance Sheet | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.25M | |||
| Cash Per Share (Q) | $0.10 | |||
| Total Current Assets (Q) | 32.60M | |||
| Total Preferred Equity (Q) | 7.95 | |||
| Total Equity (Q) | -20.27M | |||
| Current Ratio (Q) | 0.277 | |||
| Book Value Per Share (Q) | -$1.85 | |||
| Total Assets (Q) | 116.88M | |||
| Total Current Liabilities (Q) | 117.63M | |||
| Total Debt (Q) | 42.54M | |||
| Total Liabilities (Q) | 137.16M | |||
| Total Common Equity (Q) | -22.11M | |||
| Cash Flow | IDEXQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.82M | |||
| Cash from Financing (TTM) | 31.93M | |||
| Net Change in Cash (TTM) | -19.50M | |||
| Levered Free Cash Flow (TTM) | 54.20M | |||
| Cash from Operations (TTM) | -52.66M | |||
